The role of raltegravir in the treatment of HIV-2 infections: evidence from a case seriesKevin Peterson, Jean Ruelle, Marc Vekemans, Frederick P Siegal, Jane R Deayton, Robert Colebunders
Corresponding author name: Kevin Peterson
Corresponding author e-mail: email@example.com
Citation: Antiviral Therapy 2012; 17:1097-1100
Date published online: 15 August 2012
We describe five patients with HIV-2 infection (four antiretroviral-experienced and one antiretroviral-naive) treated with a regimen containing raltegravir. All responded to treatment as demonstrated by viral load and CD4+ T-cell count monitoring. Our series confirms the clinical effectiveness of raltegravir in HIV-2-infected patients when given with other antiretrovirals to which the virus is susceptible.